APA

Brown P. M., Drossman D. A., Wood A. J. J., Cline G. A., Frazier K. S., Jackson J. I., Bronner J., Freiman J., Zambrowicz B., Sands A. & Gershon M. D. (20111013). The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. : Gastroenterology.

Chicago

Brown Philip M, Drossman Douglas A, Wood Alastair J J, Cline Gary A, Frazier Kenny S, Jackson Jessica I, Bronner Johanna, Freiman Joel, Zambrowicz Brian, Sands Arthur and Gershon Michael D. 20111013. The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. : Gastroenterology.

Harvard

Brown P. M., Drossman D. A., Wood A. J. J., Cline G. A., Frazier K. S., Jackson J. I., Bronner J., Freiman J., Zambrowicz B., Sands A. and Gershon M. D. (20111013). The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. : Gastroenterology.

MLA

Brown Philip M, Drossman Douglas A, Wood Alastair J J, Cline Gary A, Frazier Kenny S, Jackson Jessica I, Bronner Johanna, Freiman Joel, Zambrowicz Brian, Sands Arthur and Gershon Michael D. The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. : Gastroenterology. 20111013.